6.50
price up icon6.38%   0.39
pre-market  시장 영업 전:  6.54   0.04   +0.62%
loading

Immuneering Corp (IMRX) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
16.56%
15.48
18.56 15.27 14.91 15.33
Operating Income/Loss
16.56%
-15.48
-18.56 -15.27 -14.91 -15.33
Income/Loss From Continuing Operations Before Tax
16.65%
-15.05
-18.05 -14.60 -14.08 -14.31
Income/Loss From Continuing Operations After Tax
16.65%
-15.05
-18.05 -14.60 -14.08 -14.31
Net Income/Loss
16.65%
-15.05
-18.05 -14.60 -14.08 -14.31
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
9,800%
35.53
0.3589 29.84 29.65 29.37
Diluted Average Shares
9,800%
35.53
0.3589 29.84 29.65 29.37
Basic Earnings Per Share
28.81%
-0.42
-0.59 -0.49 -0.47 -0.49
Diluted Earnings Per Share
28.81%
-0.42
-0.59 -0.49 -0.47 -0.49
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.38
price down icon 2.05%
$23.34
price up icon 4.71%
$32.74
price up icon 0.31%
$106.28
price up icon 0.21%
$161.81
price down icon 0.31%
biotechnology ONC
$351.09
price up icon 2.77%
자본화:     |  볼륨(24시간):